1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane has been researched along with bw a1433u in 1 studies
Studies (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Trials (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Recent Studies (post-2010) (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Studies (bw a1433u) | Trials (bw a1433u) | Recent Studies (post-2010) (bw a1433u) |
---|---|---|---|---|---|
40 | 0 | 5 | 26 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asahi, M; Mita, T; Nakahira, K; Ozoe, F; Ozoe, Y | 1 |
1 other study(ies) available for 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane and bw a1433u
Article | Year |
---|---|
The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels.
Topics: Animals; Antiparasitic Agents; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cats; Chloride Channels; Dogs; GABA Agonists; GABA Antagonists; Houseflies; Ion Channel Gating; Ligands; Mutation; Rats; Receptors, GABA; Receptors, Glutamate; Siphonaptera; Ticks; Xanthines; Xenopus | 2010 |